Zusammenfassung
Zu primären Immundefizienzen (ID) kommt es, wenn eine oder mehrere Komponenten des Immunsystems defekt sind. In den hoch industrialisierten Ländern sind die meisten ID erblich bedingt. Patienten oder Patientinnen mit einer erblichen ID fallen klinisch durch rezidivierende Infekte im Kindesalter auf. Während rezidivierende Infektionen durch pyogene Bakterien auf einen Defekt der Antikörper-, der Komplement- oder der Phagozytenfunktion hinweisen, werden virale Infektionen hauptsächlich durch die Dysregulation T-Zell-vemittelter Immunantworten verursacht.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aldrich MB, Blackburn MR, Kellems RE (2000) The importance of adenosine deaminase for lymphocyte development and function. Biochem Biophys Res Comm 272:311–315
Amiet A (1963) Aldrich Syndrom: Beobachtung zweier Fälle. Ann Paediatr 201:315–335
Andrade MA, Bork P (1995) HEAT repeats in the Huntington’s disease protein. Nat Genet 11:115–116
Apasov SG, Blackburn MR, Kellems RE, Smith PT, Sitkvsky MV (2001) Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J Clin Invest 108:131–141
Argyle JC, Kjeldsberg CR, Marty J, Shigeoka AO, Hill HR (1982) T-Cell lymphoma and the Chediak-Higashi syndrome. Blood 60:672–676
Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM (1994) Defective T-cell receptor signalling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell 76:947–958
Arredondo-Vega FX, Santisteban I, Daniels S, Toutain S, Hershfield MS (1998) Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. Am J Hum Genet 63:1049–1059
Aust MR, Andrews LG, Barrett MJ, Norby-Slycord CJ, Markert ML (1992) Molecular analysis of mutations in a patient with purine nucleoside Phosphorylase deficiency. Am J Hum Genet 51:763–772
Baba Y, Nonoyama S, Matsushita M et al. (1999) Involvement of Wiskott-Aldrich syndrome protein in in B-cell cytoplasmic tyrosine kinase pathway. Blood 93:2003–2012
Bennett CL, Christie J, Ramsdell F et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20–22
Bianchi A, Mariani S, Beggiato E et al. (1997) Distribution of T-cell signalling molecules in human myeloma. Br J Hematol 97:815–820
Brandau O, Schuster V, Weiss M et al. (1999) Epstein-Barr virus negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease. Hum Mol Genet 8:2407–2413
Brown MP, Topham DJ, Sangster MY et al. (1998) Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat Med 4:1253–1260
Buckley RH (2000) Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 343:1313–1324
Candotti F, Villa A, Notarangelo LD (1999) Severe combined immunodeficiency due to defects of JAK3 tyrosine kinase. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases Oxford University Press, New York, pp 111–120
Chan AC, Desai DM, Weiss A (1994) The role of protein tyrosine kinases and protein tyrosine phosphatases in T-cell antigen receptor signal transduction. Ann Rev Immunol 12:555–592
Clodi K, Wimmer D, Li Y et al. (2000) Expression of TRAIL receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukemia cells. Br J Haematol 111:580–586
Coffey AJ, Brooksbank RA, Brandau O et al. (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 20:129–135
Cunningham-Rundles C, Siegal FP, Cunnigham-Rundles S, Lieberman P (1987) Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 7:294–299
Derry JMJ, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635–644
De Saint-Basile G, Fischer A (2001) The role of cytotoxicity in lymphocyte homeostasis. Curr Opin Immunol 13:549–554
Dillo D, Brown M, Roskrow M et al. (1997) CD40 ligand induces an antileukemia response in vivo. Blood 90:1927–1933
Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 336:1457–148
Eck SC, Turka LA (1999) Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells. Cancer Immunol Immunother 48:336–341
Eischen CM, Williams BL, Zhang W et al. (1997) ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis. J Immunol 159:1135–1139
Fargnoli MC, Edelson RL, Berger CL et al. (1997) Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk. Leukemia 11:1338–1346
Filipovich AH, Shapiro RS, Robinson L, Mertens A, Frizzera G (1990) Lymphoproliferative disorders associated with immunodeficiency. In: Magrath IT (ed) The Non-Hodgkin’s lymphomas. Edward Arnold, London, pp 135–154
Fischer A, Hacein-Bey S, Le Deist F et al. (2000) Gene therapy of severe combined immunodeficiencies. Immunol Rev 178:13–20
Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067–1069
Grierson H, Purtiilo DT (1987) Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 106:538–545
Guinamard R, Aspenström P, Fougereau M, Chavrier P, Guillemot JC (1998) Tyrosine phosphorylation of the Wiskott-Aldrich syndrome protein by Lyn and Btk is regulated by CDC42. FEBS Lett 434:431–436
Hansson H, Mattsson PT, Allard P et al. (1998) Solution structure of the SH3 domain from Bruton’s tyrosine kinase. Biochemistry 37:2912–2924
Harrington DS, Weisenburger DD, Purtilo DT (1987) Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer 59:1419–1429
Hatada MH, Lu X, Laird ER et al. (1995) Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature 377:32–38
Hershfield MS, Kerdich NM, Ownby DR, Buckley R (1979) In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2′-desoxyadenosine in adenosine deaminase-deficient patients. J Clin Invest 63:807–811
Holinski-Feder E, Weiss M, Brandau O et al. (1998) Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics 101:276–284
Ichihara Y, Hirai M, Kurosawa Y (1992) Sequence and chromosome assignment to 11p13-p12 of human RAG genes. Immunol Lett 33:277–284
Ishii E, Yoshida N, Kimura N et al. (1999) Clonal dissemination of T-lymphocytes in seid mice from familial hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 32:201–208
Itoh N, Yonehara S, Ishii A et al. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233–243
Jackson CE, Puck JM (1999) Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. Curr Opin Pediatr 11:521–527
Janeway CA, Travers P, Walport M, Shlomchick M (2001) Immunobiology, Garland Publishing, NY, USA
Karim MA, Nagle DL, Kandil HH, Bürger J, Moore KJ, Spritz KA (1997) Mutations in the Chediak-Higashi syndrome gene (CHS1) indicate requirement for the complete 3801 amino acid CHS protein. Hum Mol Genet 6:1087–1089
Karpusas M, Hsu YM, Wang JH et al. (1995) 2A crystal structure of an extracellular fragment of human CD40 ligand. Structure 3:1031–1039
Kinlen LJ, Webster ADB, Bird AG et al. (1985) Prospective study of cancer in patients with hypogammaglobulinemia. Lancet 1:263–266
Kitada S, Zapata JM, Andreeff M, Reed JC (1999) Bryostatin and CD40 ligand enhance apoptosis resistance and induce expression of survival genes in B-cell chronic lymphocytic leukemia. Br J Haematol 106:995–1004
Knecht H, Berger C, Rothenberger S, Odermatt BF, Brousset P (2001) The role of Epstein-Barr virus in neoplastic transformation. Oncology 60:289–302
Lavilla P, Gil A, Rodriguez MCG, Dupla ML, Pintado V, Fontan G (1993) X-linked agammaglobulinemia and gastric adenocarcinoma. Cancer 72:1528–1531
Lederman HM, Winkelstein JA (1985) X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 64:145–156
Li T, Tsukada S, Satterthwaite A et al. (1995) Activation of Bruton’s tyrosine kinase (Btk) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2:451–460
Löffler G (2003) Biochemie und Pathobiochemie. Springer, Heidelberg Berlin, p 642
Macchi P, Villa A, Giliani S et al. (1995) Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65–68
Mache CJ, Slave I, Schmid C et al. (1994) Familial hemophagocytic lymphohistiocytosis associated with disseminated T-cell lymphoma: a report of two siblings. Ann Hematol 69:85–91
Markert ML (1991) Purine nucleoside Phosphorylase deficiency. Immunodef Rev 3:45–81
Martin DA, Zheng L, Siegel RM et al. (1999) Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type la. Proc Natl Acad Sci USA 96:4552–4557
Mayer L, Kwan SP, Thompson C et al. (1986) Evidence for a defect in „switch“T cells in patients with immunodeficiency and hypergammaglobulinemia. N Engl J Med 314:409–413
Menasche G, Pastural E, Feldman J et al. (2000) Mutations in RAB27A cause Griscelli syndrome associated with hemosphagocytic syndrome. Nat Genet 25:173–176
Meydan N, Grunberger T, Dadi H et al. (1996) Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379:645–648
Mikhalap SV, Shlapatska LM, Berdova AG, Law CL, Clark EA, Sidorenko SP (1999) Cdw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. J Immunol 162:5719–5727
Morra M, Howie D, Grande MS et al. (2001) X-linked lymphoproliferative disease: a progressive immunodeficiency. Ann Rev Immunol 19:657–682
Mroczek E, Weisenburger DD, Grierson HL, Markin R, Purtilo DT (1987) Fatal infectious mononucleosis and virusassociated hemophagocytic syndrome. Arch Pathol Lab Med 111:530
Nagle DL, Karim MA, Woolf EA et al. (1996) Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 14:307–311
Nakanishi M, Kikuta H, Tomizawa K et al. (1993) Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome. Cancer 72:1376–1381
Okano M, Gross TG (2000) A review of Epstein-Barr virus infection in patients with immunodeficiency disorders. Am J Med Sci 319:392–396
Parolini S, Bottino C, Falco M et al. (2000) X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function killer cells to kill Epstein-Barr virus infected cells. J Exp Med 192:337–346
Peifer M, Berg S, Reynolds AB (1994) A repeating amino acid motif shared by proteins with diverse cellular roles. Cell 76:789–791
Puck JM (1999) X-linked severe combined immunodeficiency. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases. Oxford University Press, New York, pp 99–110
Puck JM, Deschenes SM, Porter JC et al. (1993) The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 2:1099–1104
Puel A, Leonard WJ (2000) Mutations in the gene for the IL-7 receptor result in T-B+NK+ severe combined immunodeficiency disease. Curr Opin Immunol 12:468–473
Puel A, Ziegler SF, Buckley RH, Leonard WJ (1998) Defective ILR7 expression in T-B+NK+ severe combined immunodeficiency. Nat Genet 20:394–397
Ramesh N, Geha RS, Notarangelo LD (1999) CD40-ligand and the Hyper-IgM syndrome. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases. Oxford University Press, New York, pp 233–249
Ratter F, Germer M, Fischbach T et al. (1996) S-Adenosylhomocysteine as a physiological modulator of Apo-1-mediated apoptosis. Int Immunol 8:1139–1147
Remold-O’Donnell E, Cooley J, Shcherbina A et al. (1997) Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. J Immunol 158:4021–4025
Royer-Pokora B, Kunkel LM, Monaco AP et al. (1986) Cloning the gene for an inherited human disorder — chronic granulomatous disease — on the basis of its chromosomal location. Nature 322:32–38
Rozenfeld-Granot G, Toren A, Amariglio N, Brok-Simoni F, Rechavi G (2001) Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies. Exp Hematol 29:228–233
Russell SM, Tayebi N, Nakajima H et al. (1995) Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:707–800
Salim K, Bottomley MJ, Querfurth E et al. (1996) Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton’s tyro-sine kinase. EMBO J 15:6241–6250
Sayos J, Wu C, Morra M et al. (1998) The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395:462–469
Schindelhauer D, Hellebrand H, Grimm L et al. (1996) Long range map of a 3.5-Mb region in Xp11.23–22 with a sequence ready map from a 1.1 Mb gene-rich interval. Gen Res 6:1056–1069
Schultze JL, Gribben JG, Nadler LM (1998) Tumor-specific adoptive T-cell therapy for CD40+ B-cell malignancies. Curr Opin Oncol 10:542–547
Schwarz K, Hansen-Hagge TE, Knobloch C, Friedrich W, Kleihauer E, Bartram CR (1991) Severe combined immunodefiency (SCID) in man: B-cell negative (B-) SCID patients exhibit an irregular recombination pattern at the JH locus. J Exp Med 174:1039–1048
Schwarz K, Gauss GH, Ludwig L et al. (1996) RAG mutations in human B cell-negative SCID. Science 274:97–99
Seemayer TA, Gross TG, Egeler RM et al. (1995) X-linked lymphoproliferative disease: twenty-five years after the dicovery. Pediatr Res 38:471–477
Sivori S, Parlini S, Falco M et al. (2000) 2B4 functions as a co-receptor in human NK cell activation. Eur J Immunol 30:787–793
Snapper SB, Rosen FS (1999) The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization. Ann Rev Immunol 17:905–929
Stepp S, Dufourcq-Lagelouse R, Le Deist F et al. (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286:1957–1959
Strauss SE, Jaffe ES, Puck JM et al. (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194–200
Su I-J, Wang C-H, Cheng A-L, Chen R-L (1995) Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders. Leuk Lymphoma 19:401–406
Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Paediatr 125:876–885
Takemoto S, Mulloy JC, Cereseto A et al. (1997) Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA 94:13897–13902
Takeshita T, Asao H, Ohtani K et al. (1992) Cloning of the gamma chain of the human IL-2 receptor. Science 257:379–382
Taniguchi T (1995) Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251–255
Tsukada S, Saffran DC, Rawlings DJ et al. (1993) Deficient expression of a B cell tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279–290
Van der Meer JWM, Weening RS, Schellekens PTA, Van Muster IP, Nagengast FM (1993) Colorectal cancer in patients with X-linked agammaglobulinemia. Lancet 341:1439–1440
Vetrie D, Vorechovsky I, Sideras P et al. (1993) The gene involved in agammaglobulinemia is a member of the Src family of protein-tyrosine kinases. Nature 361:226–233
Vorechovsky I, Zetterquist H, Paganelli R et al. (1995) Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 77:214–218
Wang J, Zheng L, Lobito A et al. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98:47–58
Wiginton DA, Kaplan DJ, States JC et al. (1986) Complete sequence and structure of the gene for human adenosine desaminase. Biochemistry 25:3211–3217
Wildin RS, Ramsdell F, Peake J et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27:18–20
Williams SR, Gekeler V, Mclvor RS, Martin DW (1987) A human nucleoside Phosphorylase deficiency caused by a single base change. J Biol Chem 262:2332–2338
Xagoraris I, Paterakis G, Zolota B, Zikos P, Maniatis A, Mouzaki A (2001) Expression of granzyme B and perforin in multiple myeloma. Acta Haematol 105:125–129
Younes A, Carbone A (1999) CD30/CD30 ligand and CD40/CD40 ligand in malignant lymphoid disorders. Intern J Biol Markers 14:135–143
Zhu Q, Watanabe C, Liu T et al. (1997) Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP mutations, protein expression, and phenotype. Blood 90:2680–2689
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Meindl, A. (2003). Hereditäre Immundefizienzen und hämatologische Neoplasien. In: Ganten, D., Ruckpaul, K., Schlegelberger, B., Fonatsch, C. (eds) Molekularmedizinische Grundlagen von hämatologischen Neoplasien. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59343-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-59343-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63941-8
Online ISBN: 978-3-642-59343-7
eBook Packages: Springer Book Archive